Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$3.67 - $38.15 $2.16 Million - $22.5 Million
-589,138 Reduced 98.0%
12,024 $458,000
Q4 2020

Feb 17, 2021

BUY
$6.28 - $8.79 $942,000 - $1.32 Million
150,000 Added 33.25%
601,162 $4.08 Million
Q3 2020

Nov 16, 2020

BUY
$7.5 - $11.11 $840,450 - $1.24 Million
112,060 Added 33.05%
451,162 $3.38 Million
Q2 2020

Aug 14, 2020

BUY
$8.33 - $13.79 $2.29 Million - $3.79 Million
275,000 Added 429.0%
339,102 $3.56 Million
Q1 2020

May 15, 2020

BUY
$3.83 - $8.79 $245,510 - $563,456
64,102 New
64,102 $563,000

Others Institutions Holding KALA

# of Institutions
1
Shares Held
1
Call Options Held
0
Put Options Held
0

About Kala Pharmaceuticals, Inc.


  • Ticker KALA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,464,160
  • Market Cap $9.05M
  • Description
  • Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...
More about KALA
Track This Portfolio

Track Samsara Bio Capital, LLC Portfolio

Follow Samsara Bio Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Samsara Bio Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Samsara Bio Capital, LLC with notifications on news.